Company Filing History:
1 out of 1 
1 out of 14 
Years Active: 2021
Title: Mark Manfredi: Innovator in Immuno-Oncology
Introduction
Mark Manfredi is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of immuno-oncology, particularly through his innovative work on EP4 inhibitors.
Latest Patents
Mark Manfredi holds a patent for "EP4 inhibitors and use thereof." This invention provides the use of an agent that inhibits EP4 activity and an immuno-oncology agent, or a composition thereof, for the treatment of cancer. He has 1 patent to his name, showcasing his commitment to advancing cancer treatment.
Career Highlights
Throughout his career, Mark has worked with several companies, including Arrys Therapeutics, Inc. and Askat Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Mark has collaborated with notable professionals in his field, including Jeffrey Ecsedy and Atsushi Nagahisa. These partnerships have contributed to the development of his groundbreaking work in immuno-oncology.
Conclusion
Mark Manfredi's contributions to the field of immuno-oncology through his patent on EP4 inhibitors highlight his role as an innovator dedicated to improving cancer treatment. His work continues to inspire advancements in medical research and therapy.